This article is a U.S. Government work and is in the public domain in the U.S.A.
Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy†
Article first published online: 31 JUL 2006
This article is a U.S. Government work and is in the public domain in the U.S.A. Published in 2006 by John Wiley & Sons, Ltd.
Reviews in Medical Virology
Volume 16, Issue 5, pages 281–287, September/October 2006
How to Cite
Singh, N. (2006), Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy. Rev. Med. Virol., 16: 281–287. doi: 10.1002/rmv.513
- Issue published online: 25 AUG 2006
- Article first published online: 31 JUL 2006
- Manuscript Accepted: 28 MAR 2006
- Manuscript Revised: 27 MAR 2006
- Manuscript Received: 22 FEB 2006
Options for accessing this content:
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.